It’s been suggested that the newly confirmed Secretary of HHS, Xavier Becerra, poses a greater threat than his predecessor, Alex Azar, to the pharmaceutical industry. Becerra is likely, however, to focus his attention more broadly on anti-competitive practices throughout the healthcare system.
Secretary Of HHS Becerra To Focus On Anti-Competitive Practices In Hospital, PBM, And Pharmaceutical Industries
